Deck 8: Medication for Mental Disorders

Question 1

A person suffering from a chronic (long-lasting) psychotic condition for which there is no known cause will probably receive the diagnosis of ________.

A) agoraphobia
B) schizophrenia
C) bipolar disorder
D) anorexia nervosa

Answer 1

schizophrenia

Question 2

Which of the following terms primarily refers to rhythmic, repetitive sucking and smacking movements of the lips; thrusting of the tongue in and out ("fly-catching"); and movements of the arms, toes, or fingers and is the most serious complication of antipsychotic drug treatment?

A) Pseudoparkinsonism
B) Agoraphobia
C) Schizophrenia
D) Tardive dyskinesia

Answer 2

Tardive dyskinesia

Question 3

The ________ is an enzyme involved in the breakdown of serotonin, norepinephrine, and dopamine, and its suppression results in increased availability of these neurotransmitters at the synapse.

A) selective serotonin reuptake inhibitor (SSRI)
B) gamma aminobutyric acid (GABA)
C) gamma hydroxybutyrate (GHB) acid
D) monoamine oxidase (MAO) inhibitor

Answer 3

monoamine oxidase (MAO) inhibitor

Question 4

Which of the following statements is true of lithium as a mood stabilizer?

A) It causes confusion and loss of coordination if the lithium level in the blood is excessively low.
B) It acts as a mood-normalizing agent in individuals with unipolar depressions.
C) It prevents both manic and depressed mood swings.
D) It requires 1 to 2 days before disorder symptoms begin to change.

Question 5

Several studies have now found an increased risk of both weight gain and metabolic changes combined with obesity, diabetes, and cardiovascular problems in children treated with atypical antipsychotics.

Question 6

A high rate of noncompliance is the major reason why, although lithium is perhaps the single most effective psychotherapeutic agent available, alternative medications have been developed.

Question 7

Distinguish between the organic psychoses and the functional psychoses.